JP2009526793A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009526793A5 JP2009526793A5 JP2008554653A JP2008554653A JP2009526793A5 JP 2009526793 A5 JP2009526793 A5 JP 2009526793A5 JP 2008554653 A JP2008554653 A JP 2008554653A JP 2008554653 A JP2008554653 A JP 2008554653A JP 2009526793 A5 JP2009526793 A5 JP 2009526793A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- alkoxy
- independently
- hydroxy
- membered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 87
- 150000001875 compounds Chemical class 0.000 claims 53
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 51
- 229910052757 nitrogen Inorganic materials 0.000 claims 35
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims 34
- 229910005965 SO 2 Inorganic materials 0.000 claims 33
- 229910052760 oxygen Inorganic materials 0.000 claims 31
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 30
- 125000005842 heteroatom Chemical group 0.000 claims 26
- 229910052717 sulfur Inorganic materials 0.000 claims 25
- 125000001424 substituent group Chemical group 0.000 claims 20
- 239000003814 drug Substances 0.000 claims 15
- -1 N (R31) Inorganic materials 0.000 claims 14
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 11
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 11
- 125000002950 monocyclic group Chemical group 0.000 claims 11
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 10
- 239000001301 oxygen Substances 0.000 claims 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- 229910052799 carbon Inorganic materials 0.000 claims 8
- 239000011593 sulfur Substances 0.000 claims 8
- 125000004122 cyclic group Chemical group 0.000 claims 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 5
- 239000004480 active ingredient Substances 0.000 claims 5
- 125000006553 (C3-C8) cycloalkenyl group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 4
- 125000006574 non-aromatic ring group Chemical group 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 125000003003 spiro group Chemical group 0.000 claims 3
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 claims 2
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 150000001299 aldehydes Chemical class 0.000 claims 2
- 150000001491 aromatic compounds Chemical class 0.000 claims 2
- 125000002843 carboxylic acid group Chemical group 0.000 claims 2
- 230000004129 fatty acid metabolism Effects 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 125000005647 linker group Chemical group 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 229930040373 Paraformaldehyde Natural products 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000003178 anti-diabetic effect Effects 0.000 claims 1
- 239000000883 anti-obesity agent Substances 0.000 claims 1
- 229940125710 antiobesity agent Drugs 0.000 claims 1
- 150000004982 aromatic amines Chemical class 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000004980 cyclopropylene group Chemical group 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 230000002140 halogenating effect Effects 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 229920002866 paraformaldehyde Polymers 0.000 claims 1
- 150000003142 primary aromatic amines Chemical class 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- IEOPZUMPHCZMCS-ZCFIWIBFSA-N COC[C@@H]1OCCC1 Chemical compound COC[C@@H]1OCCC1 IEOPZUMPHCZMCS-ZCFIWIBFSA-N 0.000 description 1
- IEOPZUMPHCZMCS-LURJTMIESA-N COC[C@H]1OCCC1 Chemical compound COC[C@H]1OCCC1 IEOPZUMPHCZMCS-LURJTMIESA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102006007045.3 | 2006-02-15 | ||
| DE102006007045 | 2006-02-15 | ||
| PCT/EP2007/001212 WO2007093364A1 (en) | 2006-02-15 | 2007-02-13 | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009526793A JP2009526793A (ja) | 2009-07-23 |
| JP2009526793A5 true JP2009526793A5 (https=) | 2010-04-08 |
| JP5175228B2 JP5175228B2 (ja) | 2013-04-03 |
Family
ID=38191074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008554653A Expired - Fee Related JP5175228B2 (ja) | 2006-02-15 | 2007-02-13 | 新規なアザシクリル置換アリールジヒドロイソキノリノン、それらの製造方法及び薬剤としてそれらの使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8822495B2 (https=) |
| EP (1) | EP1987020B1 (https=) |
| JP (1) | JP5175228B2 (https=) |
| KR (1) | KR20080095877A (https=) |
| CN (1) | CN101384583A (https=) |
| AR (1) | AR059458A1 (https=) |
| AU (1) | AU2007214709A1 (https=) |
| BR (1) | BRPI0707872A2 (https=) |
| CA (1) | CA2636873A1 (https=) |
| CR (1) | CR10160A (https=) |
| EC (1) | ECSP088680A (https=) |
| IL (1) | IL193340A0 (https=) |
| MA (1) | MA30221B1 (https=) |
| NI (1) | NI200800217A (https=) |
| NZ (1) | NZ570503A (https=) |
| RU (1) | RU2008136898A (https=) |
| TN (1) | TNSN08326A1 (https=) |
| TW (1) | TW200800908A (https=) |
| UY (1) | UY30166A1 (https=) |
| WO (1) | WO2007093364A1 (https=) |
| ZA (1) | ZA200805939B (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7902356B2 (en) | 2004-12-17 | 2011-03-08 | Eli Lilly And Company | Thiazolopyridinone derivates as MCH receptor antagonists |
| US7728031B2 (en) | 2006-02-24 | 2010-06-01 | Abbott Laboratories | Octahydro-pyrrolo[3,4-b]pyrrole derivatives |
| MX2008015662A (es) * | 2006-06-08 | 2009-01-12 | Lilly Co Eli | Nuevos receptores antagonistas de la hormona concentradora de melanina (mch). |
| JP5225269B2 (ja) * | 2006-06-08 | 2013-07-03 | イーライ リリー アンド カンパニー | 新規なｍｃｈ受容体アンタゴニスト |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| ES2475193T3 (es) | 2007-01-22 | 2014-07-10 | Gtx, Inc. | Agentes de unión al receptor nuclear |
| US8853392B2 (en) | 2007-06-03 | 2014-10-07 | Vanderbilt University | Benzamide mGluR5 positive allosteric modulators and methods of making and using same |
| RU2486187C2 (ru) | 2007-09-11 | 2013-06-27 | Эбботт Лэборетриз | N-ОКСИДЫ ОКТАГИДРО-ПИРРОЛО[3,4-b]ПИРРОЛА |
| AR068745A1 (es) * | 2007-10-08 | 2009-12-02 | Panacea Biotec Ltd | Una composicion en forma de dosificacion farmaceutica oral de unidad de alta dosis de micofenolato sodico, metodo para utilizar dicha composicion y sus usos |
| CN101903342B (zh) * | 2007-10-17 | 2012-11-21 | 赛诺菲-安万特 | 取代的n-苯基-吡咯烷基甲基吡咯烷酰胺及其作为组胺h3受体调节剂的治疗用途 |
| CN101903340B (zh) * | 2007-10-17 | 2013-03-27 | 赛诺菲-安万特 | 取代的n-苯基联吡咯烷羧酰胺及其治疗用途 |
| US8034806B2 (en) * | 2007-11-02 | 2011-10-11 | Vanderbilt University | Bicyclic mGluR5 positive allosteric modulators and methods of making and using same |
| WO2010003624A2 (en) | 2008-07-09 | 2010-01-14 | Sanofi-Aventis | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
| US8586607B2 (en) | 2008-07-28 | 2013-11-19 | Syddansk Universitet | Compounds for the treatment of metabolic diseases |
| AR074466A1 (es) * | 2008-12-05 | 2011-01-19 | Sanofi Aventis | Piperidina espiro pirrolidinona y piperidinona sustituidas y su uso terapeutico en enfermedades mediadas por la modulacion de los receptores h3. |
| WO2010147234A1 (en) * | 2009-06-18 | 2010-12-23 | Banyu Pharmaceutical Co.,Ltd. | Diarylamide-spirodiamine derivative |
| KR101116234B1 (ko) * | 2009-10-29 | 2014-03-06 | (주)퓨쳐켐 | (3-플루오로-2-히드록시)프로필 작용기가 도입된 아릴 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
| AR083718A1 (es) | 2010-05-11 | 2013-03-20 | Sanofi Aventis | Fenil cicloalquil pirrolidina (piperidina) espirolactamas y amidas sustituidas, preparacion y uso terapeutico de las mismas |
| WO2011143155A1 (en) | 2010-05-11 | 2011-11-17 | Sanofi | Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| JP5833105B2 (ja) | 2010-05-11 | 2015-12-16 | サノフイ | 置換ｎ−ヘテロアリールスピロラクタムビピロリジン類、その製造及び治療的使用 |
| TW201206889A (en) | 2010-05-11 | 2012-02-16 | Sanofi Aventis | Substituted N-alkyl and N-acyl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| WO2011143162A1 (en) | 2010-05-11 | 2011-11-17 | Sanofi | Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
| EP2569297A1 (en) | 2010-05-11 | 2013-03-20 | Sanofi | Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| US8846713B2 (en) | 2010-06-24 | 2014-09-30 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors |
| US9134238B2 (en) * | 2010-12-01 | 2015-09-15 | Nalco Company | Method for determination of system parameters for reducing crude unit corrosion |
| TWI570122B (zh) * | 2011-06-22 | 2017-02-11 | 武田藥品工業股份有限公司 | 稠合雜環化合物之結晶 |
| CN103086894B (zh) * | 2013-02-25 | 2014-10-01 | 武汉迪可表面技术有限公司 | 一种电镀添加剂3-甲基-3-氨基丁炔的合成方法 |
| PT3030568T (pt) | 2013-08-08 | 2018-12-24 | Galapagos Nv | Tieno[2,3-c]piranos como moduladores de cftr |
| JP2021515767A (ja) | 2018-03-07 | 2021-06-24 | バイエル・アクチエンゲゼルシヤフト | Ｅｒｋ５阻害剤の同定及び使用 |
| MA53188A1 (fr) | 2018-10-11 | 2021-12-31 | Basf As | Composés aromatiques et leurs utilisations pharmaceutiques |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4329353A (en) * | 1980-10-22 | 1982-05-11 | Janssen Pharmaceutica, N.V. | 1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof |
| PT590455E (pt) * | 1992-09-28 | 2001-04-30 | Hoechst Ag | 1(2h)-isoquinolinas substituidas anti-arritmicas e cardioprotectoras processo para a sua preparacao medicamento contendo estes compostos e sua utilizacao para a preparacao de um medicamento para o combate de falhas cardiacas |
| GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| CA2468015A1 (en) * | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 2-aminoquinoline compounds |
| DE10238865A1 (de) * | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| WO2004052371A2 (en) * | 2002-12-11 | 2004-06-24 | 7Tm Pharma A/S | Cyclic quinoline compounds for use in mch receptor related disorders |
| US20060194871A1 (en) * | 2003-04-11 | 2006-08-31 | Barvian Kevin K | Heterocyclic mchr1 antagoists |
| US20070078125A1 (en) * | 2003-10-23 | 2007-04-05 | Glaxo Group Limited | Arylamine mch r1 antagonists |
| US20050256124A1 (en) * | 2004-04-15 | 2005-11-17 | Neurocrine Biosciences, Inc. | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
-
2007
- 2007-02-13 EP EP07711518A patent/EP1987020B1/en active Active
- 2007-02-13 CN CNA2007800057794A patent/CN101384583A/zh active Pending
- 2007-02-13 JP JP2008554653A patent/JP5175228B2/ja not_active Expired - Fee Related
- 2007-02-13 AU AU2007214709A patent/AU2007214709A1/en not_active Abandoned
- 2007-02-13 KR KR1020087019922A patent/KR20080095877A/ko not_active Withdrawn
- 2007-02-13 TW TW096105359A patent/TW200800908A/zh unknown
- 2007-02-13 WO PCT/EP2007/001212 patent/WO2007093364A1/en not_active Ceased
- 2007-02-13 NZ NZ570503A patent/NZ570503A/en unknown
- 2007-02-13 BR BRPI0707872-2A patent/BRPI0707872A2/pt not_active IP Right Cessation
- 2007-02-13 RU RU2008136898/04A patent/RU2008136898A/ru not_active Application Discontinuation
- 2007-02-13 CA CA002636873A patent/CA2636873A1/en not_active Abandoned
- 2007-02-15 AR ARP070100658A patent/AR059458A1/es not_active Application Discontinuation
- 2007-02-15 UY UY30166A patent/UY30166A1/es not_active Application Discontinuation
-
2008
- 2008-07-08 ZA ZA200805939A patent/ZA200805939B/xx unknown
- 2008-07-17 CR CR10160A patent/CR10160A/es not_active Application Discontinuation
- 2008-08-10 IL IL193340A patent/IL193340A0/en unknown
- 2008-08-11 TN TNP2008000326A patent/TNSN08326A1/en unknown
- 2008-08-13 EC EC2008008680A patent/ECSP088680A/es unknown
- 2008-08-14 US US12/191,662 patent/US8822495B2/en not_active Expired - Fee Related
- 2008-08-14 NI NI200800217A patent/NI200800217A/es unknown
- 2008-08-15 MA MA31180A patent/MA30221B1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009526793A5 (https=) | ||
| JP2009526795A5 (https=) | ||
| JP2009526792A5 (https=) | ||
| RU2008136898A (ru) | Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств | |
| ES2572803T3 (es) | Estimuladores de GCs | |
| US10308660B2 (en) | Compounds and compositions for inhibiting the activity of SHP2 | |
| TWI900446B (zh) | 三環性螺化合物之用途 | |
| JP2009526794A5 (https=) | ||
| CN109415360A (zh) | 用于抑制shp2活性的化合物和组合物 | |
| AU2021200164B2 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| JP7084624B2 (ja) | Ｃｘｃｒ４阻害剤およびその使用 | |
| JP2017527604A (ja) | ｓＧＣ刺激剤 | |
| JP2019518767A (ja) | Ｃｘｃｒ４阻害剤およびその使用 | |
| WO2016203406A1 (en) | Compounds and compositions for inhibiting the activity of shp2 | |
| TW200522944A (en) | CB1 modulator compounds | |
| ES2573715T3 (es) | Ligandos sigma para la prevención y/o el tratamiento del vómito inducido por la quimioterapia o la radioterapia | |
| WO2014130310A1 (en) | Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders | |
| JP2006501202A5 (https=) | ||
| JP2015178457A (ja) | ピラゾロピリジン誘導体、またはその薬理学的に許容される塩 | |
| TWI774683B (zh) | sGC刺激劑之固體形式 | |
| CN101454299A (zh) | 酰脲衍生物及其医药用途 | |
| JP2019048875A (ja) | 置換されたピペリジニル−テトラヒドロキノリン類およびそれらのα−２Ｃアドレナリン受容体拮抗薬としての使用 | |
| WO2016088813A1 (ja) | 新規ジアザビシクロ［２．２．２］オクタン誘導体 | |
| AU2018257203A1 (en) | Novel tetrahydronaphthyl urea derivatives | |
| TW200302097A (en) | Lactams as tachykinin antagonists |